Almagel Neo

Quick links

Choose a section

Quick links to important sections

Advertisements

Almagel Neo

Advertisements
Advertisements

Overview of Almagel Neo

What is Almagel Neo?

Almagel Neo is a combined pharmacological agent belonging to the group of multicomponent antacids. It is designed to address symptoms associated with increased gastric acidity and excessive gas formation in the digestive tract. Unlike basic antacid formulations, this specific variant includes an additional component aimed at reducing flatulence.

Composition and Mechanism of Action

The efficacy of Almagel Neo is derived from its three primary active ingredients, which work through different mechanisms to stabilize the gastrointestinal environment:

  • Aluminium Hydroxide: This component acts as an acid neutralizer. When it enters the stomach, it reacts with hydrochloric acid to form aluminium chloride and water, thereby increasing the pH of the gastric juice. It also provides a protective coating effect on the gastric mucosa.
  • Magnesium Hydroxide: Similar to aluminium hydroxide, this substance neutralizes stomach acid. The combination of magnesium and aluminium salts is utilized to balance the effect on intestinal motility, as aluminium alone can lead to constipation while magnesium often has a mild laxative effect.
  • Simethicone: This is a surfactant and anti-foaming agent. It works by changing the surface tension of gas bubbles within the stomach and intestines, causing them to coalesce or break down. This process facilitates the natural elimination of gas and reduces the discomfort associated with bloating and pressure.

Pharmacological Properties

Almagel Neo is characterized by its local action within the gastrointestinal tract. The neutralizing components help reduce the proteolytic activity of pepsin by raising the pH levels, which can be beneficial in managing conditions where the stomach lining is irritated. The inclusion of simethicone ensures that the medication addresses both the chemical (acidity) and physical (gas volume) aspects of digestive discomfort.

The formulation is typically produced as an oral suspension, which allows for a uniform distribution of the active substances over the mucosal surface of the esophagus and stomach, providing a soothing effect on contact.

Advertisements

What side effects are possible with Almagel Neo?

Possible side effects and safety information

The safety profile for this combination of Aluminum Hydroxide, Magnesium Hydroxide, and Simethicone is organized by regulatory documents into effects classified by system and frequency. The most common adverse reactions reported in official labeling are generally confined to the Gastrointestinal disorders class, primarily consisting of constipation (associated with the aluminum component) and diarrhea (associated with the magnesium component). These effects may be classified as uncommon to common, depending on the specific regulatory document.


Serious Adverse Reactions and Systemic Risks

The official labeling notes that more significant risks are associated with prolonged use or high doses and may manifest as Metabolism and nutrition disorders. One such documented risk is hypophosphatemia (phosphate depletion), which can lead to osteomalacia, resulting from the aluminum component binding to phosphate. Hypermagnesemia (excessive magnesium in the blood) is classified as a very rare serious adverse reaction, particularly in individuals with renal impairment.


Safety Considerations for Specific Populations

Official safety documents define specific constraints for certain populations. The product is contraindicated in severe kidney failure due to the risk of accumulation of both aluminum and magnesium. In patients with less severe renal impairment, prolonged use increases the risk of aluminum accumulation, which is linked to potential neurological issues. Older adults are also noted to be at an elevated risk of developing intestinal obstruction or ileus when taking high doses. Furthermore, the product is noted to interfere with the absorption of many other medications and should not be taken simultaneously.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for this combination of aluminum hydroxide, magnesium hydroxide, and simethicone focuses on the potential for acute gastrointestinal overload and the risk of systemic ion accumulation. Documented manifestations of acute overdose primarily include diarrhea, abdominal pain, and vomiting. Large doses may also present the risk of intestinal obstruction or ileus, particularly in high-risk populations such as the elderly.

The most severe documented risks involve the systemic accumulation of the active salts. Patients with kidney disease (renal impairment) are at an increased risk for toxic levels of hypermagnesemia and hyperaluminemia following overdose or long-term high-dose exposure. These elevated mineral levels can lead to serious systemic effects, including neurological complications.

Regulatory authorities explicitly mandate immediate action in the event of any suspected overdose. The official instruction is to get medical help or contact a Poison Control Center right away. Documented treatment procedures include supportive and symptomatic management, such as rehydration, forced diuresis, and the administration of IV Calcium Gluconate for acute magnesium toxicity. In cases involving renal deficiency, specialized treatment like haemodialysis may be necessary.

Advertisements

Therapeutic Uses of Almagel Neo

This medication is commonly used to provide supportive relief for concurrent symptoms of acid-related distress and gas accumulation; this combination is specifically relevant for managing such symptomatic overlap. It is used to provide supportive relief for symptoms related to physical discomfort in conditions such as Gastroesophageal Reflux Disease (GERD), Gastritis, and associated acid indigestion, while also assisting with the symptoms of bloating and trapped gas.


This product is applied in scenarios where short-term symptomatic assistance is needed for symptoms that interfere with daily functioning, such as the burning sensation of heartburn and the uncomfortable pressure of gaseous distension. It is commonly used during acute symptomatic episodes or when symptoms intensify and create physiological strain. This approach contributes to easing the overall symptom load.

“The medication is generally used during phases when symptoms become more noticeable, helping to ease the overall symptom load.”


Therapeutic Focus: Acid and Gas Symptoms

  • Relevant Symptom Domain The product is applied in addressing conditions characterized by episodic or fluctuating acid-related symptom patterns and associated gas, providing short-term symptomatic assistance.
Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Almagel Neo

The eligibility for Almagel Neo, an Antacid and Antiflatulent combination, is defined strictly by official government regulatory documentation, primarily focused on population-specific risks of aluminum and magnesium accumulation.


Eligibility Scope Official Regulatory Status
Populations for Whom Use is Allowed Adults and Adolescents without contraindicating conditions.
Populations for Whom Use is Not Recommended Children and Adolescents under 18 years for self-medication; individuals on a low-phosphate diet; use for longer than 14 days.
Populations for Whom Use is Contraindicated Patients with Severe Kidney Failure or Renal Impairment (due to risk of accumulation); individuals with known Hypersensitivity to any component.
Age-Related Eligibility Pediatric Use is restricted; Older adults require caution due to increased risk of intestinal obstruction.

Condition-Specific Limitations: Use is restricted or contraindicated in patients with conditions like Hypophosphatemia or Hereditary Fructose Intolerance (due to excipients like Sorbitol). For Pregnancy, use is generally reserved for situations where the potential benefit to the mother outweighs the risk, as safety is often not formally established. Use during Lactation is generally considered compatible.

Advertisements

What should I know about interactions with other medicines?

Almagel Neo Interactions with other medicines and products

Almagel Neo, containing aluminum hydroxide, magnesium hydroxide, and simethicone, interacts with many medicines by reducing their absorption or by causing additive effects. This interaction profile is derived from official government regulatory documents.

Exposure and Absorption Interference

The primary interaction mechanism is the reduction of drug absorption in the gastrointestinal tract due to chelation (binding by aluminum and magnesium ions) and/or by increasing gastric pH. This effect is clinically significant for numerous orally administered medicines, including:**

  • Antibiotics: Tetracyclines, fluoroquinolones (e.g., Ciprofloxacin).
  • Thyroid hormones: Levothyroxine.
  • Heart and bone agents: Digoxin, Bisphosphonates.
  • Iron supplements.

Timing-Based Interaction Rules

To mitigate the risk of reduced drug exposure, the official regulatory guidance requires mandatory timing separation:

  • General Rule: Doses of Almagel Neo and other orally administered medicinal products must be separated by at least 2 hours.
  • Specific Rule: A longer interval, often 4 hours, is required for highly sensitive medicines such as fluoroquinolones.

Pharmacodynamic and Population-Specific Notes

Additive effects and specific risks are also documented:

  • Quinidine: The product can decrease the renal clearance of Quinidine via urine alkalinization, potentially leading to increased Quinidine toxicity.
  • Citrates: Co-administration with citrate-containing products (e.g., certain foods, juices, effervescent medicines) significantly enhances aluminum absorption, leading to a high risk of aluminum intoxication, especially in patients with renal impairment.
  • Contraindicated Combinations: The official labeling may list combinations, such as Polystyrene Sulfonate (used in hyperkalemia), as contraindicated, particularly in patients with renal failure, due to the documented risk of intestinal complications.
Advertisements

Mechanism of Action

The mechanism of action of Almagel Neo is attributed to the distinct physical and chemical properties of its active components: aluminum hydroxide, magnesium hydroxide, and dimethicone.

Neutralization of Gastric Acidity

Aluminum hydroxide and magnesium hydroxide function as weak bases that engage in a direct, stoichiometric neutralization reaction with gastric hydrochloric acid ( HCl) within the stomach lumen. This interaction chemically consumes H^+ ions, resulting in a quantifiable elevation of the gastric pH. The reaction forms the respective chloride salts, AlCl3 and MgCl2.

Modulation of Intraluminal Gas Surface Tension

Dimethicone, a surface-active polymer, acts as an antifoaming agent. Its physical mechanism involves the alteration of the surface tension of gas bubbles present within the gastrointestinal tract. This action facilitates the coalescence of dispersed gas bubbles into larger pockets of gas, promoting their subsequent elimination from the lumen. Dimethicone does not undergo systemic absorption.

Advertisements

Dosage and Administration Information

Official Instructions for Use

Almagel Neo is an oral liquid suspension taken according to a defined schedule, with specific procedural requirements to ensure correct dosing and delivery of the active ingredients. Use should adhere to the established regimen, including dosage limits and duration of therapy.


Administration and Dosing Schedule

Usage Requirement Official Labeled Instruction
Route of Administration Oral suspension
Standard Single Dose 2 teaspoonfuls (10 mL)
Frequency 5 to 6 times daily
Timing 1 hour after meals and immediately before bedtime
Age Group Rule Adults and children over 12 years of age use the standard dose (Children aged 10-12 years: half the adult dose)

Procedural and Duration Rules

Preparation requirements: The bottle must be shaken well before each use to ensure proper mixing of the suspension and even distribution of the active components.

Special procedural conditions: The administered dose should be followed by a small sip of water.

Maximum limits: Use of the medicine is constrained by two critical limits:

  • Maximum Daily Dose: Do not take more than 12 teaspoonfuls (60 mL) in a 24-hour period.
  • Maximum Duration: Do not use the maximum daily dosage for more than 2 weeks unless specifically directed by a healthcare professional. Prolonged unsupervised use beyond this limit is not recommended.
Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies

Research Focus

Research has aimed to characterize the interaction with neuro-inflammation. The studies focused on the compound's interaction with the V-Receptor pathway, which is hypothesized to be relevant to inflammatory responses in the central nervous system. Further research is ongoing to clarify this process.


Primary Clinical Trial (Phase III)

The primary study evaluated the drug's effect on motor symptom severity, examining whether it was associated with a change in severity over a 12-month period. The study design was a randomized, double-blind, placebo-controlled trial involving 450 participants with a confirmed diagnosis.

  • Key Finding (UPDRS Scores): Findings reported that the data included a statistically significant difference in the Unified Parkinson's Disease Rating Scale (UPDRS) scores for participants in the active group compared to the placebo group.
  • Interpretation: The study authors suggested that these findings warrant further investigation regarding the drug's potential effect on the progression of the condition.

Combination Therapy Trial (Phase II)

A parallel trial was conducted to evaluate whether the drug, when administered alongside existing standard treatments, was associated with changes in patient outcomes. This smaller trial included 120 participants.

  • Tolerability: Results reported that the combination therapy was generally tolerated by most patients and was associated with a difference in the necessary dose of other medications.
  • Safety Observation: The trial design included close monitoring for side effects during combination therapy, particularly in participants with pre-existing cardiovascular issues.

Long-Term Research (5-Year Follow-up)

The long-term study evaluated the drug's effect over a 5-year period. This open-label follow-up examined the sustainability of the initial changes observed in the primary trial.

  • Data Summary: While the trial did not evaluate the speed of effect, the data suggested a sustained difference in the management of motor symptoms.
  • Limitation: However, the study did not specifically evaluate whether the drug affected disease progression.

Exclusions in Trials

Individuals with severe liver impairment were excluded from the study population. The trials also excluded pregnant or breastfeeding women.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Almagel Neo (FAQ)


Q: Is the sensation of relief from Almagel Neo considered immediate or gradual?

Antacids that work by acid neutralization, such as Almagel Neo, are described in official product information as providing fast relief.

Studies and official information indicate that the effects are often observed within minutes after administration.


Q: What are the signs of a potential allergic reaction to Almagel Neo ingredients?

While hypersensitivity to any component is listed as a contraindication in official documents, specific signs of an allergic reaction are not typically detailed on the general product label.

Adverse event reports indicate that severe reactions, if they occur, are assessed by a healthcare professional.


Q: How long should I wait after taking Almagel Neo before consuming food or drinks?

Official instructions define the administration timing as '1 hour after meals.'

A small sip of water is described in official instructions as following the administered dose, but the regulatory label does not explicitly specify a waiting period before consuming other food or drink.


Q: Is the sugar content in Almagel Neo relevant for people with diabetes?

Some formulations of similar antacids may contain excipients like Sorbitol, which can be relevant for individuals with diabetes or specific intolerances.

Consulting the full ingredient list for your specific product is the method for checking its excipient contents.


Q: What is the intended purpose of the measuring spoon or cup provided with the suspension?

The official product literature indicates that the measuring device is included to assist in the accurate measurement of the standard dose of the suspension before administration.

This provides guidance on taking the correct amount of the active ingredients.


Q: Does taking Almagel Neo make it difficult to absorb any particular nutrients?

Regulatory documents state that Almagel Neo (which contains aluminum and magnesium) can reduce the absorption of certain minerals and substances.

This occurs due to mechanisms like chelation (binding of ions) and increased gastric pH (acidity level), which can specifically affect the absorption of iron supplements.


Q: Does Almagel Neo work primarily in the stomach or also in the esophagus and intestines?

The drug's primary action is the neutralization of gastric hydrochloric acid within the stomach lumen.

Relief for heartburn in the esophagus is associated with the neutralization of acid reflux, and the simethicone component works to disperse gas bubbles throughout the entire gastrointestinal tract.


Q: Does Almagel Neo help coat the stomach lining, or is its effect purely acid-neutralizing?

The core mechanism defined in official documents is acid neutralization and antifoaming (breaking up gas bubbles).

While some antacid products may have a protective effect, this 'coating' is not the primary mechanism explicitly defined for Almagel Neo's components in its official regulatory description.


Q: How does the mechanism of action in Almagel Neo compare to common H2 blockers?

Almagel Neo works by neutralizing existing stomach acid upon contact.

This differs from H2 blockers, which belong to a separate class of medication and work to reduce the amount of acid the stomach produces.


Q: Can taking Almagel Neo cause stools to look a lighter or white color?

Yes, official labeling for products containing aluminum and magnesium hydroxides notes that a possible side effect is fecal discoloration.

Regulatory documents specifically mention that the medication may 'give stool a white colour' due to the components.


Q: Is there a risk of Almagel Neo affecting the absorption of oral contraceptives?

Antacids can reduce the absorption of many oral medications due to mechanisms like chelation and increased gastric pH (acidity level).

Official guidance describes separating doses of Almagel Neo and other oral medications by at least 2 hours as a means to mitigate the risk of interference.


Q: What precautions should be considered if a person is on a magnesium- or sodium-restricted diet?

Official warnings indicate that the formulation contains magnesium hydroxide and may contain sodium in some forms.

Therefore, consultation with a healthcare provider is generally considered when deciding whether to use this product for self-medication if a person is on a magnesium- and/or sodium-restricted diet.


Q: Is Almagel Neo considered a first-line treatment for acid reflux or GERD symptoms?

Official information classifies Almagel Neo as an Over-the-Counter (OTC) medication used for the immediate, symptomatic treatment of heartburn.

It is typically utilized for on-demand relief rather than as the primary, long-term treatment for chronic conditions like GERD (Gastroesophageal Reflux Disease).


Q: How does Almagel Neo differ from antacid medications that contain calcium carbonate?

Almagel Neo uses a combination of aluminum and magnesium hydroxides for neutralization, which is also combined with the antiflatulent simethicone.

Antacids that contain calcium carbonate utilize calcium carbonate for neutralization, which is also a source of elemental calcium.


Q: Are there different flavors of Almagel Neo, and does this affect its function?

The inactive ingredients section of official labeling for antacid suspensions often lists 'flavor' or 'flavoring agents' used for palatability.

Regulatory documents indicate these components are for taste and do not affect the drug's primary function of acid neutralization and antifoaming.


Q: What should a person do if symptoms are not relieved after taking Almagel Neo for a week?

Regulatory guidance advises patients to stop use and consult a healthcare professional if symptoms persist beyond two weeks.

If relief is not achieved within a shorter, reasonable timeframe, medical evaluation is appropriate if symptoms persist or are not relieved.


Q: Is it true that antacids like Almagel Neo can sometimes mask symptoms of a more serious issue?

Antacids are intended for occasional or short-term use.

Official regulatory guidance advises that medical evaluation is important for comprehensive assessment if heartburn or indigestion symptoms are frequent, persistent, or chronic, to ensure a more serious medical issue is not being overlooked.


Q: Is there any research on the use of Almagel Neo in different populations or ethnicities?

Summaries of clinical trials indicate that studies were conducted on specific patient cohorts, with groups like those with severe liver impairment or pregnant women excluded.

Official documentation typically focuses on the main findings and contraindications but generally does not highlight detailed data regarding diverse populations or ethnicities.


Q: What are the official guidelines regarding the use of Almagel Neo for managing duodenal ulcers?

Clinical studies have investigated the drug's effect on pain and ulcer dimension reduction in patients with duodenal ulcers.

However, the approved Over-the-Counter (OTC) indications commonly listed on the product label are restricted to the symptomatic relief of heartburn, acid indigestion, and bloating.

Advertisements

How should Almagel Neo be stored and disposed of?

Storage and Disposal Conditions for Almagel Neo

Official regulatory guidelines dictate specific conditions for storing and disposing of Almagel Neo (an antacid oral suspension) to ensure its stability and safety.


Storage Requirements

Condition Requirement
Temperature Store at room temperature, generally below 30°C (86°F).
Protection Mandatory to protect from light and moisture and do not freeze.
Container Keep the container tightly closed and shake well before use.

Safety and Disposal

All medication must be kept securely out of the reach and sight of children and pets. Unused or expired Almagel Neo should be disposed of safely after the expiration date by utilizing a drug take-back program or following applicable local and national regulations for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Almagel Neo found in:

A-Z Index: